We hence performed a preliminar analysis of RAB7A protein levels on only 12 matched tumor tissues of patients for which both the naïve (pre-chemotherapy) and the post-chemotherapy residual tumor tissues were available within the Mitochondria in Progression of Endometrial and Ovarian cancers (MiPEO) study. This evidence concerns the gene RAB7A and neoplasm.